Financial Architects, Inc Teva Pharmaceutical Industries LTD Transaction History

Financial Architects, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$8.57 - $12.69 $3,428 - $5,076	-400 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $15,833 - $30,654	-1,950 Reduced 82.98%	400 $4,000
Q1 2019 May 13, 2019	BUY	$15.58 - $20.01 $33,497 - $43,021	2,150 Added 1075.0%	2,350 $36,000
Q1 2019 May 03, 2019	SELL	$15.58 - $20.01 $12,464 - $16,008	-800 Reduced 80.0%	200 $3,000
Q2 2018 Aug 03, 2018	SELL	$16.77 - $24.71 $3,354 - $4,942	-200 Reduced 16.67%	1,000 $24,000
Q1 2018 Apr 23, 2018	SELL	$16.68 - $22.07 $11,676 - $15,449	-700 Reduced 36.84%	1,200 $21,000
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $17,968 - $30,560	-1,600 Reduced 45.71%	1,900 $36,000
Q3 2017 Nov 01, 2017	BUY	$15.41 - $32.17 $49,312 - $102,944	3,200 Added 1066.67%	3,500 $62,000
Q3 2017 Oct 23, 2017	BUY	$15.41 - $32.17 $4,623 - $9,651	300	300 $5,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.